PALS Provider Course

Incorrect. Compressions at 1/3 the depth of the chest ensure adequate perfusion without risking internal injuries.

Incorrect. Atropine is administered at 0.02 mg/kg IV/IO for pediatric bradycardia due to vagal stimulation or primary AV block.

Incorrect. IV access is the preferred route for drug delivery during resuscitation, ensuring rapid and reliable administration.

Incorrect. Respiratory failure leads to hypoxia, which is the most frequent cause of bradycardia in children.

Incorrect. The jaw thrust avoids neck movement and is preferred for maintaining the airway in patients with suspected cervical spine injuries.

Incorrect. Compressions for children should be performed with the heel of one or both hands, depending on the child's size.

Incorrect. Amiodarone is the preferred antiarrhythmic for stabilizing wide-complex tachycardia in pediatric patients.

Incorrect. Fluid resuscitation restores perfusion, and antibiotics address the infection causing septic shock.

Incorrect. Asystole is a non-shockable rhythm requiring immediate CPR and epinephrine administration.

Incorrect. Delivering 8-10 breaths per minute ensures adequate oxygenation without hyperventilation during CPR with an advanced airway.

Incorrect. A 30:2 ratio is used for single-rescuer CPR in pediatric patients to ensure adequate circulation and oxygenation.

Incorrect. Adenosine is used to terminate reentrant arrhythmias in SVT by slowing conduction through the AV node.

Incorrect. IM epinephrine is the first-line treatment to reduce airway swelling and improve oxygenation.

Incorrect. Rhythm checks are performed every 2 minutes to assess the need for defibrillation or changes in treatment.

Incorrect. PEA is a non-shockable rhythm and is treated with high-quality CPR, epinephrine, and addressing reversible causes.

Incorrect. During advanced airway CPR, breaths are delivered at 6-8 seconds (10 breaths/min) without pausing chest compressions.

Incorrect. Epinephrine is administered to improve perfusion and heart rate in bradycardia unresponsive to oxygen.

Incorrect. Epinephrine IM is administered immediately to address airway swelling and improve respiratory function in anaphylaxis.

Incorrect. Intramuscular epinephrine is the first-line treatment for pediatric anaphylaxis, administered into the mid-thigh.

Incorrect. Hypoglycemia is a reversible cause of cardiac arrest and is treated by correcting blood glucose levels.

Incorrect. Rhythm checks are performed every 2 minutes to evaluate for shockable rhythms or changes in the patient’s condition.

Incorrect. Adenosine is administered at 0.1 mg/kg as a rapid IV push for treating narrow-complex SVT in children.

Incorrect. Waveform capnography is the most reliable method to confirm and monitor proper ET tube placement in pediatric patients.

Incorrect. CPR is initiated to relieve the obstruction and restore ventilation when a child becomes unresponsive.

Incorrect. Asystole is a non-shockable rhythm requiring high-quality CPR and epinephrine administration.

Incorrect. The initial defibrillation dose for pediatric VF is 2 J/kg, increasing to 4 J/kg for subsequent shocks if needed.

Incorrect. In cardiogenic shock, smaller fluid boluses of 5-10 mL/kg are preferred to avoid fluid overload and worsening cardiac function.

Incorrect. Tension pneumothorax is a treatable cause of cardiac arrest, managed by needle decompression to relieve intrathoracic pressure.

Incorrect. Magnesium sulfate is the treatment of choice for torsades de pointes in pediatric patients, not lidocaine.

Incorrect. Oxygen improves perfusion and is the first-line treatment for bradycardia caused by hypoxia.

Incorrect. The total cumulative dose of amiodarone during pediatric cardiac arrest should not exceed 15 mg/kg.

Incorrect. Amiodarone is administered at 5 mg/kg IV/IO during pediatric cardiac arrest for refractory VF or pulseless VT.

Incorrect. Neonates require oxygen saturation levels of 90-95% to support optimal oxygen delivery without causing hyperoxia.

Incorrect. A PETCO2 value above 10 mmHg indicates adequate chest compressions and cardiac output during CPR.

Incorrect. CPR is initiated immediately to relieve the obstruction and restore ventilation in an unresponsive child.

Incorrect. Limiting fluid boluses to 10 mL/kg prevents fluid overload and worsening cardiac function in cardiogenic shock.

Incorrect. Hypovolemia is a reversible cause and is treated with fluid resuscitation to restore circulating volume and perfusion.

Incorrect. If VF persists after the initial defibrillation at 2 J/kg, the next dose is 4 J/kg, and subsequent shocks should not exceed 10 J/kg.

Incorrect. Neonates receive a 10 mL/kg isotonic crystalloid bolus to treat hypovolemic shock while avoiding fluid overload.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore a perfusing rhythm in pediatric cardiac arrest.

Incorrect. Atropine should not exceed a total dose of 3 mg to avoid adverse effects during pediatric bradycardia treatment.

Incorrect. Magnesium sulfate is the treatment of choice for torsades de pointes, stabilizing the myocardium and correcting QT interval abnormalities.

Incorrect. Oxygen improves perfusion and reduces hypoxia in children with poor perfusion but a palpable pulse.

Incorrect. Synchronized cardioversion restores a stable rhythm in unstable SVT that is refractory to adenosine.

Incorrect. Pediatric defibrillation starts at 2 J/kg and may increase to 4 J/kg for subsequent shocks if needed.

Incorrect. Immediate defibrillation is crucial to restoring a perfusing rhythm in shockable cardiac arrest.

Incorrect. A compression fraction greater than 80% ensures that most of the resuscitation time is spent on chest compressions.

Incorrect. Oxygen delivery stabilizes respiratory distress and improves oxygen saturation in pediatric patients.

Incorrect. Tension pneumothorax is included in the “T’s” of reversible causes and is treated with needle decompression to relieve pressure.

Incorrect. If no rhythm is detected, CPR is continued immediately to maintain perfusion until further intervention is possible.

Incorrect. Magnesium sulfate is the treatment of choice for torsades de pointes, stabilizing cardiac cells and correcting QT prolongation.

Incorrect. Neonatal oxygen saturation gradually increases after birth, reaching 80-85% within the first 5 minutes.

Incorrect. The target oxygen saturation during the first 5 minutes of neonatal resuscitation is 80-85%, gradually increasing to 90-95%.

Incorrect. The initial defibrillation dose for pediatric VF is 2 J/kg, increasing to 4 J/kg for subsequent shocks if needed.

Incorrect. Vagal maneuvers are used to terminate stable SVT by increasing parasympathetic stimulation to the AV node.

Incorrect. Magnesium sulfate stabilizes the myocardium and is used to treat torsades de pointes in children.

Incorrect. High-quality CPR is continued while addressing any potential reversible causes in pediatric PEA.

Incorrect. Needle decompression relieves pressure and restores ventilation in cases of tension pneumothorax.

Incorrect. Hypoxia is the leading cause of pediatric bradycardia and should be addressed with oxygenation and ventilation.

Incorrect. A 20 mL/kg bolus of isotonic crystalloid is recommended for children in hypovolemic shock.

Incorrect. A 20 mL/kg fluid bolus is standard for pediatric hypovolemic shock to restore circulating volume.

Incorrect. PEA is a non-shockable rhythm and is managed with high-quality CPR, epinephrine, and addressing reversible causes.

Incorrect. A 30:2 ratio ensures sufficient oxygenation and circulation when only one rescuer is available for pediatric CPR.

Incorrect. The maximum atropine dose for pediatric bradycardia is 3 mg total, with individual doses capped at 0.5 mg for children.

Incorrect. Synchronized cardioversion is indicated in unstable SVT to restore a normal sinus rhythm safely.